Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Helus Pharma Inc.

Helus Pharma Inc. (HELP) Stock Overview

Explore Helus Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

HELP●NASDAQ
HealthcareMedical - Pharmaceuticals
$8.80
$1.79(16.94%)
U.S. Market opens in 5h 8m

Helus Pharma Inc. (HELP)

Meyka AI Score

Z

Key Financials

Market Cap545.5M
P/E Ratio-1.64
EPS (TTM)$-4.16
ROE-0.71%
Fundamental Analysis

AI Price Forecasts

1 Month$8.80
3 Months$11.69
1 Year Target$9.79

HELP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Helus Pharma Inc. (NASDAQ: HELP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Helus Pharma Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HELP on the NASDAQ shows an RSI of 31.66, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $9.79 for the NASDAQ listing.

Key metrics behind Helus Pharma Inc.'s NASDAQ-traded stock include a P/E ratio of -1.64 and a market capitalization of 545.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HELP on the NASDAQ.

Price Performance (NASDAQ: HELP)

1-Day Change
-16.94%
5-Day Change
-17.22%
1-Month Change
-24.79%
3-Month Change
12.53%
6-Month Change
70.87%
Year-to-Date (YTD) Change
7.58%
1-Year Change
48.90%
3-Year Change
48.90%
5-Year Change
48.90%
All-Time (Max) Change
48.90%

Contact Information

https://www.helus.com
908 764 8385
100 King Street West, Suite 5600, Toronto, ON, M5X 1C9

Company Facts

1,000 Employees
IPO DateSep 13, 2019
CountryCA
Actively Trading

Frequently Asked Questions